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T cell motility as modulator of
interactions with dendritic cells
Jens V. Stein*
Theodor Kocher Institute, University of Bern, Bern, Switzerland
It is well established that the balance of costimulatory and inhibitory signals during
interactions with dendritic cells (DCs) determines T cell transition from a naïve to an
activated or tolerant/anergic status. Although many of these molecular interactions are
well reproduced in reductionist in vitro assays, the highly dynamic motility of naïve T cells
in lymphoid tissue acts as an additional lever to fine-tune their activation threshold. T
cell detachment from DCs providing suboptimal stimulation allows them to search for
DCs with higher levels of stimulatory signals, while storing a transient memory of short
encounters. In turn, adhesion of weakly reactive T cells to DCs presenting peptides
presented on major histocompatibility complex with low affinity is prevented by lipid
mediators. Finally, controlled recruitment of CD8+ T cells to cognate DC–CD4+ T cell
clusters shapes memory T cell formation and the quality of the immune response.
Dynamic physiological lymphocyte motility therefore constitutes a mechanism to mitigate
low avidity T cell activation and to improve the search for “optimal” DCs, while contributing
to peripheral tolerance induction in the absence of inflammation.
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T LYMPHOCYTES ARE CELLS THAT SCAN
THE SURFACES OF OTHER CELLS
A defining feature of T cells is their ability to become activated by pathogen-derived peptides
presented on major histocompatibility complexes (pMHCs), while remaining quiescent when self-
peptides are presented. Although in vitro experiments have successfully delineated the molecular
requirements for TCR triggering and continue to serve as important experimental tool to analyze
T cell activation, there is a factor that is difficult to reproduce in reductionist in vitro approaches:
isolated naive T cells are typically immotile in vitro without prior activation, whereas these cells
are remarkably motile in vivo. Direct observation of T cell behavior using intravital two photon
microscopy (2PM) has shown that these cells have a polarized, amoeboid-like shape, and move in
resting lymphoid tissue with speeds of ~12–15μm/min, in an apparently random manner (1–5).
Similarly, effector T cells in non-lymphoid tissues, including leptomeningeal membranes (6), liver
(7), and pancreas (8), show continuous motility, although the tissue microarchitecture is likely to
restrict T cell motility, in particular, in tightly packed epithelial layers of the skin (9). The dynamic
motility has evolved because T cells are MHC restricted and therefore need to physically scan the
surfaces of other cells. This process is balancedwith rapid decision-making onwhether to arrest (e.g.,
to exert cytotoxic activity against a target cell) or to continue migration. A central feature of T cell
biology is therefore their ability to transit from a highly motile to a stationary phenotype, i.e., from
vigorous scanning to firm adhesion. Decision-making of whether to “stop” or to “go” is probably
most critical in lymphoid tissue, such as peripheral lymph nodes (PLNs), where T cells move with
highest speeds and are therefore only in short contact with pMHC-presenting dendritic cells (DCs).
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In fact, it has been estimated that each DC is contacted by
~500–5000 T cells per hour, mostly for less than a few min (10,
11). This raises two questions: first, how is the T cell motility
induced in lymphoid tissue, and second, which factors influence
T cell decision-making for fast arrest?
REGULATION OF T CELL MOTILITY
IN LYMPHOID TISSUE
The PLN parenchyme consists of a sponge-like network of loosely
spaced fibroblastic reticular cells (FRCs) expressing the promi-
gratory chemokines CCL19 and CCL21, ligands for the CCR7
chemokine receptor present on naïve T cells (12). DCs are closely
attached to the FRC network to facilitate their continuous scan-
ning by T cells (13). Furthermore, the LFA-1 ligands ICAM-1 and
ICAM-2 are expressed on both DCs and FRCs, while CCL21 is
deposited onDCs (14, 15). 2PM imaging experiments have shown
that CCR7 ligands and LFA-1–ICAM-1 interactions contribute to
basalmigration, although even in their absence, T cells retain their
amoeboidmigrationmode and attain considerable average speeds
of ~10–12μm/min (16–19). In line with these observations, T
cells lacking the Gαi2 subunit acting downstream of CCR7 move
only slightly slower than WT T cells in PLN parenchyme (20).
Chemokines and integrins induce T cell polarization and the
formation of a leading edge and uropod as a result of multiple
signaling cascades revised elsewhere (21–24). In brief, continuous
Rac-mediated F-actin assembly at the leading edge, or lamel-
lipodium, provides the protrusion force in 3D environments,
even in the absence of integrin ligands (25). This is reflected
in T cells lacking the DOCK2 guanine exchange factor for the
small GTPase Rac1 and 2. These cells display strongly impaired
in vitro motility (26), and similar to Rac1/2-double-deficient T
cells, show virtually no residual migration in PLN parenchyme
(27, 28). Thus, LFA-1, CCR7, and other, as of yet unknown factors
lead to DOCK2–Rac-driven T cell motility. The importance of
this pathway for host surveillance is underscored by the recent
identification of DOCK2-deficient patients, who suffer from early
onset severe invasive infections (29).
Furthermore, lysophosphatidic acid (LPA) produced by the
exoenzyme autotaxin (ATX) on stromal cells, including high
endothelial venules (HEVs) and FRCs, contributes to transmigra-
tion and basal lymphocyte motility in PLNs (30–34). LPA binds
to T cell-expressed LPA2, a member of the GPCR family, and
induces Rho activation, which cooperates with CCL21 to induce
contractility-dependent lymphocyte migration. Pharmacological
blocking of ATX or LPA receptors or lack of LPA2 reduces T cell
speeds by ~30% in vivo, while addition of LPA increases T cell
polarization and speeds in vitro (30, 31, 33). These observations
are in line with recent descriptions of increased cell motility gen-
erated by augmented contractility of the trailing edge in confined
environments (35, 36). Similarly, T cells crossing endothelial bar-
riers is facilitated by theRho-GTP effector ROCKandMyosin IIA-
mediated contractility to move the nucleus through narrow pores
and for detachment of LFA-1–ICAM-1 adhesions (25, 37, 38).
Finally, in vitro and in vivo experiments support a role for tyrosine
kinase signaling downstream chemokine receptor signaling in T
cells. Thus, inhibition with Janus kinases (JAK) prevents T cell
chemotaxis to CCL21, adhesion to HEVs and homing (39–41). Of
note, interstitial motility within lymphoid tissue was not affected
by the absence of JAK1 and JAK2, pointing to compensatory
mechanisms that ensure robust motility.
DYNAMIC CONTROL OF T CELL ARREST
Ground-breaking work by Dustin and colleagues has uncovered
that in vitro generated chemotactic gradients, including the pro-
totypic T cell-attracting chemokine CCL21, are capable to disrupt
TCR–pMHC complexes, leading to detachment from antigen-
presenting cells and blunted T cell activation (42, 43). Although
CCL21 gradients have been confirmed in interfollicular regions
of PLNs (44), it remains unclear whether such gradients exist in
the paracortical T cell zone or around HEVs, where naive T cells
first encounter DCs (45). Interestingly, mice lacking promigra-
tory CCR7 ligands show a delayed but ultimately enhanced T
cell responses during immune responses (46). The delayed onset
may result from lack of efficient T cell–DC encounters at early
time points, while exceeding T cell responses at later time points
are consistent with an immunosuppressive action of CCL21 via
disruption of weakly reactive T cell – DC interactions.
Two photon microscopy analysis has helped to subdivide T
cell–DC interactions into distinct phases that are regulated by sur-
face levels of pMHC on DCs, as well as the TCR–pMHC affinity.
Thus, high levels of cognate pMHC are able to induce immediate
arrest of reactive T cells, whereas low levels result in a continuous
scanning behavior of T cells (47–49). During scanning, which can
last up to 8 h and is referred to as “phase 1,” T cells are able to
summate signals through activeNFAT and c-fos signaling (50, 51).
In addition to pMHC, ICAM-1 onDCs facilitates T cell arrest (52),
whereas regulatory T cells (Tregs) prevent stable interactions with
DCs in this phase (53, 54). “Phase 2” stable T cell–DC interactions
last for several hours and are commonly thought to be critical for
full T cell activation through the formation of an immunological
synapse (IS). Thus far, the precise duration of individual stable
T cell–DC contacts has proven difficult to assess in vivo, owing
to technical limitations maintaining physiological conditions and
the identical field of view during intravital imaging. After ~20 h
post T cell transfer, activated T cells resume motility and detach
from DCs before committing to cell division, in the so-called
phase 3 (Figure 1A).
Early in vitro evidence suggests that decision-making leading to
arrest on DCs may require only a few seconds and correlates with
induction of Ca flux in responsive T cells (56, 57). Interestingly,
dynamic DOCK2-driven F-actin assembly at the leading edge of
motile T cells ismaintained during interactionswithDCs, butwith
a different spatial arrangement at the IS interface. TCR signal-
ing and ICAM-1–LFA-1-mediated adhesion convert Rac-driven
protrusion activity at the lamellipodium of migrating T cells into
an annular F-actin ring with centripetal directionality at the IS
interface (58, 59). Combining these in vitro observations with
2PM data, the decision-making of motile T cells to undergo con-
version from translocation to arrest requires a threshold pMHC
level on DCs, sufficient integrated signals from previous DC
encounters and LFA-1-mediated firm adhesion. Weak activatory
signals because of low pMHC levels, low TCR–pMHC affinity or
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FIGURE 1 |Motile T cell–DC interactions in lymphoid tissue. (A) Phases
of interactions between pMHC-loaded DCs and T cells after their entry into
lymph nodes. Phase 1 is characterized by transient interactions, whereas T
cells engage stably with DCs during phase 2. In phase 3, T cells detach from
DCs and begin to divide before egressing as effector T cells. Adapted from
Ref. (55). (B) Regulation of weak T cell–DC interactions by TXA2 secretion.
TP-induced motility prevents stable T cell attachment (phase 1–2 transition)
unless a critical pMHC threshold is presented on DCs, thus ensuring a high
quality of ensuing CD4+ T cell responses. (C) Secretion of CCR5 ligands
CCL3 and CCL4 by pairs of interacting CD4+ T cells and DCs attract naïve
CD8+ T cells and helps to foster CD4+ T cell help. By contrast, excessive
CCR5 ligand production in the absence of Tregs deteriorates the quality of
CD8+ T cell responses by allowing weakly interacting clones to attach to DCs.
lack of ICAM-1 on DCs would be insufficient to trigger F-actin
conversion to a ring-like structure. Consistent with this model,
inhibitory receptors of TCR signaling including CTLA-4 and PD-
1 prevent T cell adhesion to antigen-presenting cells (60–62).
Recent work by Krummel and colleagues has shown that naïve
T cells express Myo1g, a regulator of membrane tension. When
T cells are exposed to physical pressure, Myo1g accumulates at
the spot of pressure exertion, followed by adjacent generation of a
newly formed F-actin protrusion (63). In vitro and in vivo assays
uncovered that Myo1g activity results in a meandering migra-
tion pattern, since Myo1g-deficient T cells showed less turning
behavior and higher directionality. As a result, Myo1g-deficient
T cells displayed shorter interaction times with DCs in vivo, as the
average scanning time decreased from~1.7 to 1min. This reduced
interaction time had a significant impact for T cell engagement
with rare DCs, sinceMyo1g-deficient T cells were unable to “read”
enough DC activation signals for arrest conversion and main-
tained their migratory behavior (63). In sum, in vivo migrating
T cells need a minimal DC scanning time of ~100 s to integrate
sufficient TCR signals for a successful conversion of protruding
to annular F-actin and IS formation. This process is supported by
LFA-1 adhesion to ICAM-1 on DCs.
THROMBOXANE A2-INDUCED MOTILITY
AS QUALITY CONTROL FOR CD4+ T CELL
RESPONSES
Activated DCs increase surface expression of costimulatory
molecules and are therefore able to efficiently activate T cells,
including weakly reactive or potentially self-reactive clones.
Work by Sanui and colleagues has identified activated DCs and
macrophages as important source of thromboxane A2 (TXA2).
TXA2 is a secreted lipid with short half-life that binds the
Gα12/13-coupled TP receptor expressed on naïve but not effec-
tor/memory T cells. Binding of TXA2 to TP induces lsc (also
known as p115 RhoGEF or ArhGEF1)-mediated Rho activation
(64), which induces chemokinetic motility in vitro and disruption
of T cell–DC pairs (65). In a recent study, TXA2 was shown
to specifically thwart the activation of weakly reactive CD4+ T
cell clones. After immunization or infection, Ag-specific CD4+
T cells that bound tetramers only weakly expanded significantly
more in the absence of TP. Using 2PM imaging of reactive PLNs,
the absence of TP on naïve CD4+ T cells resulted in increased
interactions with DCs presenting low amounts or weak agonist
pMHC, leading to a premature phase 1 to phase 2 transition and
excessive T cell expansion (Figure 1B). By contrast, WT- and TP-
deficient CD4+ T cells similarly engaged with DCs presenting
high amounts of agonist pMHC, indicating that TXA2 preferen-
tially prevents arrest of weakly reactive T cell clones (66). Thus,
TXA2 allows T cells to maintain their search for DCs present-
ing high levels of cognate pMHC, rather than weak agonist or
self-peptides. Indeed, TXA2-mediated quality control of early T
cell–DC interactions prevented the excessive generation of follic-
ular helper cells, which provide help to weakly reactive germinal
center B cells. As consequence, lack of TXA2–TP signaling during
T cell priming deteriorated the overall quality of the ensuing
immune response (66).
TIGHTLY REGULATED CCR5 LIGAND
EXPRESSION CONTROLS THE QUALITY
OF CD8+ T CELL RESPONSES
A comparable link between the quality of adaptive immune
responses and low affinity-driven interactions was made when
examining how the absence of Tregs affected CD8+ T cell
engagement with DCs. Previous work had shown that baseline
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production of CCR5 ligands CCL3 and CCL4 leads to the recruit-
ment of naive CD8+ T cells to DC engaged in productive inter-
actions with CD4+ T cells, resulting in CD4+ T cell help and
effective CD8+ T cell memory formation (67). By contrast,
in the absence of Tregs, DCs produced increased amounts of
CCR5 ligands that facilitated excessive engagement of CD8+
T cells with DCs presenting low-affinity pMHC complexes as
assessed by 2PM imaging (Figure 1C). This resulted in an overall
lower quality of the adaptive immune responses, since the ratio
of low versus high avidity clones was shifted towards the for-
mer population (68). Thus, similar to TXA2, motility-inducing
agents influence T cell–DC interactions inside reactive PLNs
that contain highly stimulatory DCs. It is interesting to note
that in non-reactive PLNs, the absence of CCR5 ligand produc-
tion and TXA2 permits unbiased scanning of resident DCs by
naïve T cells, which is essential for efficient peripheral tolerance
education.
CONCLUDING REMARKS
Two photon microscopy-based investigation of T cell–DC inter-
actions has uncovered factors that, in addition to pMHC abun-
dance and affinity, regulate the dynamic interplay between these
two cell types. Although tightly regulated T cell attraction to
activated DCs promote adaptive immune responses by allowing
rare cells to meet, excessive interactions with low-affinity pMHC-
presentingDCs deteriorate the overall quality of clonal expansion.
Furthermore, intrinsic wiring of the migratory behavior of T cells
facilitates their scanning function. Thus, programmed Myo1g-
induced meandering behavior permits sufficiently long interac-
tions between T cells and DCs. In addition, continuous F-actin
treadmilling during both migration and IS formation endows
T cells with the capacity to quickly switch between migratory
versus stationary modes. Thus, upon cessation of TCR signaling,
T cells resume their motility, presumably to avoid overstimu-
lation and to prepare for egress. These observations raise new
interesting questions. For example, is the duration of phase 2-like
stable interactions regulated by external chemoattractant gradi-
ents or cell-intrinsic mechanisms? Furthermore, desensitization
of chemokine receptors, such as CCR5, and its impact on T cell
motility patterns in vivo has not been investigated in detail. Such
studies are relevant since CCR5 ligands attract cognate and non-
cognate naïve CD8+ T cells, andwould rapidly limit access toDCs
unless CCR5 desensitization is allowing cell turnover. The con-
tinued examination of mechanisms that control T cell motility in
lymphoid tissue and their impact on adaptive immune responses
will remain a productive field of research in years to come.
ACKNOWLEDGMENTS
The Stein laboratory is funded by Swiss National Foundation
grants 31003A_135649, CR23I3_156234, and CRSII3_141918,
FP7Marie Curie RG grant 276702, and Swiss Cancer League grant
KFS-3524-08-2014.
REFERENCES
1. Wei SH, Parker I, Miller MJ, Cahalan MD. A stochastic view of lympho-
cyte motility and trafficking within the lymph node. Immunol Rev (2003)
195:136–59. doi:10.1034/j.1600-065X.2003.00076.x
2. Germain R, Miller M, Dustin M, Nussenzweig M. Dynamic imaging of the
immune system: progress, pitfalls and promise. Nat Rev Immunol (2006)
6:497–507. doi:10.1038/nri1884
3. Sumen C, Mempel TR, Mazo IB, Andrian Von UH. Intravital microscopy:
visualizing immunity in context. Immunity (2004) 21:315–29. doi:10.1016/j.
immuni.2004.08.006
4. Breart B, Bousso P. Cellular orchestration of T cell priming in lymph nodes.
Curr Opin Immunol (2006) 18:483–90. doi:10.1016/j.coi.2006.05.006
5. Friedl P, Weigelin B. Interstitial leukocyte migration and immune function.Nat
Immunol (2008) 9:960–9. doi:10.1038/ni.f.212
6. Bartholomäus I, Kawakami N, Odoardi F, Schläger C, Miljkovic D, Ellwart
JW, et al. Effector T cell interactions with meningeal vascular structures in
nascent autoimmune CNS lesions. Nature (2009) 462:94–8. doi:10.1038/
nature08478
7. Guidotti LG, Inverso D, Sironi L, Di Lucia P, Fioravanti J, Ganzer L, et al.
Immunosurveillance of the liver by intravascular effector CD8+ T Cells. Cell
(2015) 161:486–500. doi:10.1016/j.cell.2015.03.005
8. Coppieters K, Amirian N, Herrath von M. Intravital imaging of CTLs killing
islet cells in diabetic mice. J Clin Invest (2012) 122:119–31. doi:10.1172/
JCI59285
9. Gebhardt T, Whitney PG, Zaid A, Mackay LK, Brooks AG, Heath WR, et al.
Different patterns of peripheral migration by memory CD4+ and CD8+ T cells.
Nature (2011) 477:216–9. doi:10.1038/nature10339
10. Bousso P, Robey E. Dynamics of CD8+T cell priming by dendritic cells in intact
lymph nodes. Nat Immunol (2003) 4:579–85. doi:10.1038/ni928
11. Miller MJ, Hejazi AS,Wei SH, CahalanMD, Parker I. T cell repertoire scanning
is promoted by dynamic dendritic cell behavior and random T cell motility in
the lymph node. Proc Natl Acad Sci U S A (2004) 101:998–1003. doi:10.1073/
pnas.0306407101
12. Bajénoff M, Egen JG, Qi H, Huang AYC, Castellino F, Germain RN. Highways,
byways and breadcrumbs: directing lymphocyte traffic in the lymph node.
Trends Immunol (2007) 28:346–52. doi:10.1016/j.it.2007.06.005
13. Katakai T, Habiro K, Kinashi T. Dendritic cells regulate high-speed interstitial
T cell migration in the lymph node via LFA-1/ICAM-1. J Immunol (2013)
191:1188–1199. doi:10.4049/jimmunol.1300739
14. Boscacci RT, Pfeiffer F, Gollmer K, Sevilla AIC, Martin AM, Soriano SF,
et al. Comprehensive analysis of lymph node stroma-expressed Ig superfamily
members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and
VCAM-1 in lymphocyte homing. Blood (2010) 116:915–25. doi:10.1182/blood-
2009-11-254334
15. Wendland M, Willenzon S, Kocks J, Davalos-Misslitz AC, Hammerschmidt
SI, Schumann K, et al. Lymph node T cell homeostasis relies on steady state
homing of dendritic cells. Immunity (2011) 35:945–57. doi:10.1016/j.immuni.
2011.10.017
16. Okada T, Cyster J. CC chemokine receptor 7 contributes to Gi-dependent T cell
motility in the lymph node. J Immunol (2007) 178:2973. doi:10.4049/jimmunol.
178.5.2973
17. Worbs T, Mempel TR, Bölter J, Andrian Von UH, Förster R. CCR7 ligands
stimulate the intranodal motility of T lymphocytes in vivo. J Exp Med (2007)
204:489–95. doi:10.1084/jem.20061706
18. Asperti-Boursin F, Real E, Bismuth G, Trautmann A, Donnadieu E. CCR7 lig-
ands control basal T cellmotility within lymphnode slices in a phosphoinositide
3-kinase-independent manner. J Exp Med (2007) 204:1167–79. doi:10.1084/
jem.20062079
19. Woolf E, Grigorova I, Sagiv A, Grabovsky V, Feigelson SW, Shulman Z, et al.
Lymph node chemokines promote sustained T lymphocyte motility without
triggering stable integrin adhesiveness in the absence of shear forces. Nat
Immunol (2007) 8:1076–85. doi:10.1038/ni1499
20. Hwang I, Park C, Kehrl J. Impaired trafficking of Gnai2and Gnai2-/-T lym-
phocytes: implications for T cell movement within lymph nodes. J Immunol
(2007) 179:439. doi:10.4049/jimmunol.179.1.439
21. Krummel MF, Macara I. Maintenance and modulation of T cell polarity. Nat
Immunol (2006) 7:1143–9. doi:10.1038/ni1404
Frontiers in Immunology | www.frontiersin.org November 2015 | Volume 6 | Article 5594
Stein Motility controls T cell activation
22. Thelen M, Stein J. How chemokines invite leukocytes to dance. Nat Immunol
(2008) 9:953–9. doi:10.1038/ni.f.207
23. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflam-
mation: the leukocyte adhesion cascade updated. Nat Rev Immunol (2007)
7:678–89. doi:10.1038/nri2156
24. Niggli V. Insights into the mechanism for dictating polarity in migrating T-
cells. Int Rev Cell Mol Biol (2014) 312:201–70. doi:10.1016/B978-0-12-800178-
3.00007-5
25. Lämmermann T, Bader BL,Monkley SJ,Worbs T,Wedlich-Söldner R, Hirsch K,
et al. Rapid leukocyte migration by integrin-independent flowing and squeez-
ing. Nature (2008) 453:51–5. doi:10.1038/nature06887
26. Fukui Y, Hashimoto O, Sanui T, Oono T, Koga H, Abe M, et al. Haematopoietic
cell-specific CDM family proteinDOCK2 is essential for lymphocytemigration.
Nature (2001) 412:826–31. doi:10.1038/35090591
27. Nombela-Arrieta C, Mempel TR, Soriano SF, Mazo I, Wymann MP, Hirsch
E, et al. A central role for DOCK2 during interstitial lymphocyte motility
and sphingosine-1-phosphate-mediated egress. J Exp Med (2007) 204:497–510.
doi:10.1084/jem.20061780
28. FaroudiM, HonsM, Zachacz A, Dumont C, Lyck R, Stein JV, et al. Critical roles
for Rac GTPases in T-cell migration to and within lymph nodes. Blood (2010)
116:5536–47. doi:10.1182/blood-2010-08-299438
29. Dobbs K, Domínguez Conde C, Zhang S-Y, Parolini S, Audry M, Chou J, et al.
Inherited DOCK2 deficiency in patients with early-onset invasive infections.N
Engl J Med (2015) 372:2409–22. doi:10.1056/NEJMoa1413462
30. Katakai T, Kondo N, Ueda Y, Kinashi T. Autotaxin produced by stromal cells
promotes LFA-1-independent and Rho-dependent interstitial T cell motility
in the lymph node paracortex. J Immunol (2014) 193:617–26. doi:10.4049/
jimmunol.1400565
31. Knowlden SA, Capece T, Popovic M, Chapman TJ, Rezaee F, Kim M, et al.
Regulation of T cell motility in vitro and in vivo by LPA and LPA2. PLoS One
(2014) 9:e101655. doi:10.1371/journal.pone.0101655
32. Bai Z, Cai L, Umemoto E, Takeda A, Tohya K, Komai Y, et al. Constitutive
lymphocyte transmigration across the basal lamina of high endothelial venules
is regulated by the autotaxin/lysophosphatidic acid axis. J Immunol (2013)
190:2036–48. doi:10.4049/jimmunol.1202025
33. Zhang Y, Chen Y-CM, Krummel MF, Rosen SD. Autotaxin through
lysophosphatidic acid stimulates polarization, motility, and transendothelial
migration of naive T cells. J Immunol (2012) 189:3914–24. doi:10.4049/
jimmunol.1201604
34. Kanda H, Newton R, Klein R, Morita Y, Gunn MD, Rosen SD. Autotaxin,
an ectoenzyme that produces lysophosphatidic acid, promotes the entry of
lymphocytes into secondary lymphoid organs. Nat Immunol (2008) 9:415–23.
doi:10.1038/ni1573
35. Liu Y-J, Le Berre M, Lautenschlaeger F, Maiuri P, Callan-Jones A, Heuzé M,
et al. Confinement and low adhesion induce fast amoeboid migration of slow
mesenchymal cells. Cell (2015) 160:659–72. doi:10.1016/j.cell.2015.01.007
36. Ruprecht V, Wieser S, Callan-Jones A, Smutny M, Morita H, Sako K, et al.
Cortical contractility triggers a stochastic switch to fast amoeboid cell motility.
Cell (2015) 160:673–85. doi:10.1016/j.cell.2015.01.008
37. Jacobelli J, Estin Matthews M, Chen S, Krummel MF. Activated T cell trans-
endothelial migration relies on myosin-IIA contractility for squeezing the cell
nucleus through endothelial cell barriers. PLoS One (2013) 8:e75151. doi:10.
1371/journal.pone.0075151
38. Soriano SF, Hons M, Schumann K, Kumar V, Dennier TJ, Lyck R, et al. In vivo
analysis of uropod function during physiological T cell trafficking. J Immunol
(2011) 187:2356–64. doi:10.4049/jimmunol.1100935
39. Pérez-Rivero G, Cascio G, Soriano SF, Sanz ÁG, de Guinoa JS, Rodríguez-Frade
JM, et al. Janus kinases 1 and 2 regulate chemokine-mediated integrin activation
and naïve T-cell homing. Eur J Immunol (2013) 43:1745–57. doi:10.1002/eji.
201243178
40. Stein JV, Soriano SF, M’rini C, Nombela-Arrieta C, de Buitrago GG, Rodríguez-
Frade JM, et al. CCR7-mediated physiological lymphocyte homing involves
activation of a tyrosine kinase pathway. Blood (2003) 101:38–44. doi:10.1182/
blood-2002-03-0841
41. Montresor A, Bolomini-Vittori M, Toffali L, Rossi B, Constantin G, Laudanna
C. JAK tyrosine kinases promote hierarchical activation of Rho and Rap mod-
ules of integrin activation. J Cell Biol (2013) 203:1003–19. doi:10.1083/jcb.
201303067
42. Bromley SK, Peterson DA, Gunn MD, Dustin ML. Cutting edge: hierarchy of
chemokine receptor and TCR signals regulating T cell migration and prolifera-
tion. J Immunol (2000) 165:15–9. doi:10.4049/jimmunol.165.1.15
43. Dustin ML. Stop and go traffic to tune T cell responses. Immunity (2004)
21:305–14. doi:10.1016/j.immuni.2004.08.016
44. Ulvmar MH, Werth K, Braun A, Kelay P, Hub E, Eller K, et al. The atypi-
cal chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph
nodes. Nat Immunol (2014) 15:623–30. doi:10.1038/ni.2889
45. Bajenoff M, Granjeaud S, Guerder S. The strategy of T cell antigen-presenting
cell encounter in antigen-draining lymph nodes revealed by imaging of initial
T cell activation. J Exp Med (2003) 198:715–24. doi:10.1084/jem.20030167
46. Mori S, Nakano H, Aritomi K, Wang C, Gunn M, Kakiuchi T. Mice lacking
expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate
delayed but enhanced T cell immune responses. J Exp Med (2001) 193:207.
doi:10.1084/jem.193.2.207
47. Mempel TR, Henrickson SE, Andrian Von UH. T-cell priming by dendritic
cells in lymph nodes occurs in three distinct phases. Nature (2004) 427:154–9.
doi:10.1038/nature02238
48. Henrickson SE, Mempel TR, Mazo IB, Liu B, Artyomov MN, Zheng H, et al.
T cell sensing of antigen dose governs interactive behavior with dendritic cells
and sets a threshold for T cell activation.Nat Immunol (2008) 9:282–91. doi:10.
1038/ni1559
49. Henrickson SE, Perro M, Loughhead SM, Senman B, Stutte S, Quigley M,
et al. Antigen availability determines CD8+ T cell-dendritic cell interaction
kinetics and memory fate decisions. Immunity (2013) 39:496–507. doi:10.1016/
j.immuni.2013.08.034
50. Clark CE, HasanM, Bousso P. A role for the immediate early gene product c-fos
in imprinting T cells with short-termmemory for signal summation. PLoS One
(2011) 6:e18916. doi:10.1371/journal.pone.0018916
51. Marangoni F, Murooka TT, Manzo T, Kim EY, Carrizosa E, Elpek NM, et al.
The transcription factor NFAT exhibits signal memory during serial T cell
interactions with antigen-presenting cells. Immunity (2013) 38:237–49. doi:10.
1016/j.immuni.2012.09.012
52. Scholer A, Hugues S, Boissonnas A, Fetler L, Amigorena S. Intercellular adhe-
sion molecule-1-dependent stable interactions between T cells and dendritic
cells determine CD8+ T cell memory. Immunity (2008) 28:258–70. doi:10.1016/
j.immuni.2007.12.016
53. Tadokoro CE, Shakhar G, Shen S, Ding Y, Lino AC,Maraver A, et al. Regulatory
T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo.
J Exp Med (2006) 203:505–11. doi:10.1084/jem.20050783
54. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, et al. Visualizing regu-
latory T cell control of autoimmune responses in nonobese diabetic mice. Nat
Immunol (2006) 7:83–92. doi:10.1038/ni1289
55. Bousso P. T-cell activation by dendritic cells in the lymph node: lessons from
the movies. Nat Rev Immunol (2008) 8:675–84. doi:10.1038/nri2379
56. Donnadieu E, Bismuth G, Trautmann A. Antigen recognition by helper T cells
elicits a sequence of distinct changes of their shape and intracellular calcium.
Curr Biol (1994) 4:584–95. doi:10.1016/S0960-9822(00)00130-5
57. Negulescu PA, Krasieva TB, Khan A, Kerschbaum HH, Cahalan MD. Polarity
of T cell shape, motility, and sensitivity to antigen. Immunity (1996) 4:421–30.
doi:10.1016/S1074-7613(00)80409-4
58. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, et al.
The immunological synapse: a molecular machine controlling T cell activation.
Science (1999) 285:221–7. doi:10.1126/science.285.5425.221
59. Le Floc’h A, Tanaka Y, Bantilan NS, Voisinne G, Altan-Bonnet G, Fukui Y,
et al. Annular PIP3 accumulation controls actin architecture and modulates
cytotoxicity at the immunological synapse. J Exp Med (2013) 210:2721–37.
doi:10.1016/j.cub.2005.12.024
60. Schneider H, Downey J, Smith A, Zinselmeyer BH, Rush C, Brewer JM, et al.
Reversal of the TCR stop signal by CTLA-4. Science (2006) 313:1972–5. doi:10.
1126/science.1131078
61. Fife BT, Pauken KE, Eagar TN, Obu T,Wu J, Tang Q, et al. Interactions between
PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.
Nat Immunol (2009) 10:1185–92. doi:10.1038/ni.1790
62. Honda T, Egen JG, Lämmermann T, Kastenmuller W, Torabi-Parizi P, Ger-
main RN. Tuning of antigen sensitivity by T cell receptor-dependent negative
feedback controls T cell effector function in inflamed tissues. Immunity (2014)
40:235–47. doi:10.1016/j.immuni.2013.11.017
Frontiers in Immunology | www.frontiersin.org November 2015 | Volume 6 | Article 5595
Stein Motility controls T cell activation
63. Gérard A, Patiño-López G, Beemiller P, Nambiar R, Ben-Aissa K, Liu Y, et al.
Detection of rare antigen-presenting cells through T cell-intrinsic meandering
motility, mediated by Myo1g. Cell (2014) 158:492–505. doi:10.1016/j.cell.2014.
05.044
64. Harenberg A, Girkontaite I, Giehl K, Fischer K-D. The Lsc RhoGEF mediates
signaling from thromboxane A2 to actin polymerization and apoptosis in
thymocytes. Eur J Immunol (2005) 35:1977–86. doi:10.1002/eji.200425769
65. Kabashima K, Murata T, Tanaka H, Matsuoka T, Sakata D, Yoshida N, et al.
Thromboxane A2 modulates interaction of dendritic cells and T cells and reg-
ulates acquired immunity. Nat Immunol (2003) 4:694–701. doi:10.1038/ni943
66. Moalli F, Cupovic J, Thelen F, Halbherr P, Fukui Y, Narumiya S, et al. Throm-
boxane A2 acts as tonic immunoregulator by preferential disruption of low-
avidity CD4+ T cell-dendritic cell interactions. J Exp Med (2014) 211:2507–17.
doi:10.1084/jem.20140137
67. Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain
RN. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of
CD4+ T cell-dendritic cell interaction. Nature (2006) 440:890–5. doi:10.1038/
nature04651
68. Pace L, Tempez A, Arnold-Schrauf C, Lemaitre F, Bousso P, Fetler L, et al.
Regulatory T cells increase the avidity of primary CD8+ T cell responses and
promote memory. Science (2012) 338:532–6. doi:10.1126/science.1227049
Conflict of Interest Statement: The author declares that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Copyright © 2015 Stein. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordancewith
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Immunology | www.frontiersin.org November 2015 | Volume 6 | Article 5596
